CLINAM 2018

Opening Address from the European Foundation for Clinical Nanomedicine

Introduction: Workforce in Medicine

Prions: Deadly Self‐replicating Nanomachines

The EU‐US Cooperation on Characterization of Nanopharmaceuticals

Emerging Regulatory Guidance for Nanomedicine and the Need for Innovator‐Regulator Interaction...

Global Collaborations in Regulatory Science and Standards Development

Dr. Borgos, New Frontiers in Characterizations: the Example of Liposomal Irinotecan Nanomedicine

Developing Cell‐targeted, Brain‐penetrating Polymeric Nano‐micelles to Treat Neurodegenerative...

Monitoring and Modulating Innate Immunity Using Nanomaterials

Nanostructure and the Formation Mechanism of Extracellular Vesicles Studied by State‐of‐the‐art...

Entry of Nanoparticles into Cells: Mechanisms and Consequences

Challenges and Opportunities of Nanomedicine Approaches to Induce Immune Tolerance and Cure Type...

inhibiting macrophage infiltration to prime to the tumor vasculature and microenviornment...

Biodegradable Silicon Nanoparticles for Targeted Treatment of Bacterial Infection

Single Particle Measurement of Number, Size and Charge is required for Confidence in Nanomedicine...

Opening Address from the Swiss Government

Multimodal Imaging for Evaluating the Behavior of Nanomaterials in Vivo

Intravenously Injectable mRNA‐lipoplex Nanoparticles for Tumor Immunotherapy: Clinical Update...

Overview of Swiss Personalized Health Network SPHN

Employing the Protein Corona to Address Dendritic Cells

Next Generation Species‐Specific, Eco‐Friendly Antibiotics and Thoughts about Origin of Life

Bionispired molecular factories from Artificial Organelles to Artificial Cell mimics

CriPec® Platform and Lead Product CriPec® Docetaxel: Principles, Preparation, Biomedical...

Nanomedicine Safety Testing in a Porcine Model: Questions Regarding Validity for Preclinical...